189 related articles for article (PubMed ID: 31413608)
21. Three once-weekly intra-articular injections of Hylan G-F 20 significantly improve pain relief compared with placebo in patients with chronic idiopathic knee osteoarthritis: a single-centre, evaluator-blinded and patient-blinded, randomized controlled trial.
Langworthy M; Lascarides P; Ngai W; Steele K; Huang Y
Drugs Context; 2024; 13():. PubMed ID: 38601838
[TBL] [Abstract][Full Text] [Related]
22. Severe Acute Localized Reactions Following Intra-Articular Hyaluronic Acid Injections in Knee Osteoarthritis.
Ong KL; Runa M; Xiao Z; Ngai W; Lau E; Altman RD
Cartilage; 2021 Dec; 13(1_suppl):1474S-1486S. PubMed ID: 32063023
[TBL] [Abstract][Full Text] [Related]
23. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients.
Lee S; Park D; Chmell SJ
J Knee Surg; 2004 Apr; 17(2):73-7. PubMed ID: 15124659
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and Tolerability of Repeated Courses of Viscosupplementation in Symptomatic Hip Osteoarthritis: A Retrospective Observational Cohort Study of High Molecular Weight
De Lucia O; Pierannunzii LM; Pregnolato F; Verduci E; Crotti C; Valcamonica E; Pisoni L; Comi D; Lonati PA; Meroni PL; Murgo A
Front Pharmacol; 2019; 10():1007. PubMed ID: 31616292
[No Abstract] [Full Text] [Related]
25. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
26. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.
Chevalier X; Jerosch J; Goupille P; van Dijk N; Luyten FP; Scott DL; Bailleul F; Pavelka K
Ann Rheum Dis; 2010 Jan; 69(1):113-9. PubMed ID: 19304567
[TBL] [Abstract][Full Text] [Related]
27. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.
Wobig M; Dickhut A; Maier R; Vetter G
Clin Ther; 1998; 20(3):410-23. PubMed ID: 9663358
[TBL] [Abstract][Full Text] [Related]
28. One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: a systematic literature review and meta-analysis.
De Lucia O; Jerosch J; Yoon S; Sayre T; Ngai W; Filippou G
Clin Rheumatol; 2021 Jun; 40(6):2133-2142. PubMed ID: 33108530
[TBL] [Abstract][Full Text] [Related]
29. Three Weekly Intra-Articular Injections of Hylan G-F 20 vs Arthrocentesis in Patients with Chronic Idiopathic Knee Osteoarthritis: A Multicenter, Evaluator- and Patient-Blinded, Randomized Controlled Trial.
Huang Y; Lascarides P; Ngai W; Steele K; Hummer CD
Curr Ther Res Clin Exp; 2023; 99():100707. PubMed ID: 37408828
[TBL] [Abstract][Full Text] [Related]
30. Assessing the Impact of a Novel Smartphone Application Compared With Standard Follow-Up on Mobility of Patients With Knee Osteoarthritis Following Treatment With Hylan G-F 20: A Randomized Controlled Trial.
Skrepnik N; Spitzer A; Altman R; Hoekstra J; Stewart J; Toselli R
JMIR Mhealth Uhealth; 2017 May; 5(5):e64. PubMed ID: 28487266
[TBL] [Abstract][Full Text] [Related]
31. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
Conrozier T; Vignon E
Clin Exp Rheumatol; 2005; 23(5):711-6. PubMed ID: 16173254
[TBL] [Abstract][Full Text] [Related]
32. Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone.
Vad VB; Bhat AL; Sculco TP; Wickiewicz TL
Arch Phys Med Rehabil; 2003 May; 84(5):634-7. PubMed ID: 12736873
[TBL] [Abstract][Full Text] [Related]
33. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
[TBL] [Abstract][Full Text] [Related]
34. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy.
Huskin JP; Vandekerckhove B; Delincé P; Verdonk R; Dubuc JE; Willems S; Hardy P; Blanco FJ; Charrois O; Handelberg F
Knee Surg Sports Traumatol Arthrosc; 2008 Aug; 16(8):747-52. PubMed ID: 18536906
[TBL] [Abstract][Full Text] [Related]
35. Hip viscosupplementation under ultra-sound guidance riduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry.
Migliore A; Granata M; Tormenta S; Laganà B; Piscitelli P; Bizzi E; Massafra U; Alimonti A; Maggi C; De Chiara R; Iannessi F; Sanfilippo A; Sotera R; Scapato P; Carducci S; Persod P; Denaro S; Camminiti M; Pagano MG; Bagnato G; Iolascon G
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):25-34. PubMed ID: 21381497
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial.
Leopold SS; Redd BB; Warme WJ; Wehrle PA; Pettis PD; Shott S
J Bone Joint Surg Am; 2003 Jul; 85(7):1197-203. PubMed ID: 12851342
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation.
De Lucia O; Luppino AF; Pregnolato F; Murgo A; Pontikaki I; Gattinara M; Ubiali T; Cimaz R; Caporali R
Adv Ther; 2022 Mar; 39(3):1267-1278. PubMed ID: 35038122
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review.
Espallargues M; Pons JM
Int J Technol Assess Health Care; 2003; 19(1):41-56. PubMed ID: 12701938
[TBL] [Abstract][Full Text] [Related]
39. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
[TBL] [Abstract][Full Text] [Related]
40. Improvement in condition-specific and generic quality of life outcomes in patients with knee osteoarthritis following single-injection Synvisc: results from the LOBRAS study.
Kearey P; Popple AE; Warren J; Davis T; Bellamy N;
Curr Med Res Opin; 2017 Mar; 33(3):409-419. PubMed ID: 27848271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
